Oritavancin Longitudinal In Vitro Activity Against Gram-positive Organisms from USA Medical Centers: Results from the SENTRY Antimicrobial Surveillance Program for 2010-2014
Oritavancin Longitudinal In Vitro Activity Against Gram-positive Organisms from USA Medical Centers: Results from the SENTRY Antimicrobial Surveillance Program for 2010-2014, Lead author: Mendes RE, presented at 1st annual American Society for Microbiology General Meeting (MICROBE), June 16 – 20, 2016, Boston, Massachusetts, USA
Saturday-345
